The characteristics of the paper used are an important consideration in the manufacture of sensitivity discs. Because of the use of paper as matrix in this product, these characteristics rank highly as potential sources of variation in the performance of discs. The various manufacturers have selected papers suitable to the requirements for their final products. The specifications of these papers vary somewhat as to weight, thickness, anid absorbability of water. For this very reason, paper must play a major role in the standardization of discs. The proposed regulations of the Food and Drug Administration (FDA) for the assay of discs (Anonymous, 1960) specify the paper to be used for the preparation of the control discs. This present work was undertaken to answer questions raised about the reproducibility of results that can be obtained with different commercial batches of paper of the specified grade. In this publication "different batches" refer to paper of the same specifications but manufactured at different times, whereas "different grades" refer to papers with different specifications.
The Food and Drug Administration specifies that the blank discs used in the control of commercial discs "be 14 inch in diameter, of paper weighing approximately 30 mg per square centimeter that will absorb approximately 3 times its weight of distilled water." Ostrander and Griffith (1959) used an exquisitely sensitive indicator organism in a study of the effects of 16 different papers used to make penicillin discs. With this sensitive organism, two units of penicillin is in the upper range of concentrations where further increases of concentration produce no further response. This study indicated that unless some other agents, such as certain dyes, were present, the paper used made no difference in the performance of the disc.
In our study the organisms used were those designated in the FDA proposed regulations.' Each of these organisms was originally selected because its sensitivity is such that an essentially linear response is obtained to the concentrations of antibiotics used. The batch differences in paper for any antibiotic or all antibiotics combined at a probability level of P = 0.05. Table 2 summarizes the results of these trials. Even without analysis the performance differences are obvious. The Seed Test paper gave significantly smaller zones with chlortetracycline and penicillin, and no zones with neomycin or polymyxin. Whatman no. 1 paper gave significantly larger zones than the paper meeting FDA specifications. Figures 1 and 2 illustrate these performances.
Part 2

DIscussIoN
The question has been raised as to just how reproducible are results obtained with control discs made from different commercial batches of paper of the grade specified by the Food and Drug Administration. In view of the lack of significant batch to batch performance differences among four papers that meet these specifications, it is apparent that reproducible results can be obtained when such papers are used for the preparation of control discs. Further, in view of the large differences demonstrated among papers of different grades, it is most desirable that control discs be prepared from a given kind of paper, such as that specified. By eliminating the variation due to papers used in preparing control discs in the manufacturer's laboratories, it is possible to have a standard of comparison which is reproducible from one laboratory to another. Thus, in the clinical use of antibiotic discs one can be assured of similar results in testing clinical cultures, regardless of which manufacturer's discs are used.
